Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E S Moland

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Clinical Microbiology|August 15, 1998
Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?E S Moland, C C Sanders, K S Thomson
Diagnostic Microbiology and Infectious Disease|May 5, 2001
Activity of oral agents against pediatric isolates of Streptococcus pneumoniaeJ Black, E S Moland, S A Chartrand, et al.
The Pediatric Infectious Disease Journal|August 1, 1996
Colonization with penicillin-nonsusceptible Streptococcus pneumoniae in urban and rural child-care centersD J Boken, S A Chartrand, E S Moland, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 2001
Activity of faropenem against resistant isolates of Streptococcus pneumoniaeJ A Black, E S Moland, S A Chartrand, et al.
The Journal of Antimicrobial Chemotherapy|December 20, 1999
Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacinA Pong, K S Thomson, E S Moland, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1997
Beta-lactamases and detection of beta-lactam resistance in Enterobacter sppJ D Pitout, E S Moland, C C Sanders, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1995
New variant of TEM-10 beta-lactamase gene produced by a clinical isolate of proteus mirabilisT Palzkill, K S Thomson, C C Sanders, et al.
The Journal of Antimicrobial Chemotherapy|October 8, 1999
Molecular characterization of a multiply resistant Klebsiella pneumoniae encoding ESBLs and a plasmid-mediated AmpCN D Hanson, K S Thomson, E S Moland, et al.
Journal of Clinical Microbiology|December 4, 2009
Positive extended-spectrum-beta-lactamase (ESBL) screening results may be due to AmpC beta-lactamases more often than to ESBLsG K Munier, C L Johnson, J W Snyder, et al.
Antimicrobial Agents and Chemotherapy|June 13, 1998
beta-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South AfricaJ D Pitout, K S Thomson, N D Hanson, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Clinical Microbiology|August 15, 1998
Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?E S Moland, C C Sanders, K S Thomson
Diagnostic Microbiology and Infectious Disease|May 5, 2001
Activity of oral agents against pediatric isolates of Streptococcus pneumoniaeJ Black, E S Moland, S A Chartrand, et al.
The Pediatric Infectious Disease Journal|August 1, 1996
Colonization with penicillin-nonsusceptible Streptococcus pneumoniae in urban and rural child-care centersD J Boken, S A Chartrand, E S Moland, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 2001
Activity of faropenem against resistant isolates of Streptococcus pneumoniaeJ A Black, E S Moland, S A Chartrand, et al.
The Journal of Antimicrobial Chemotherapy|December 20, 1999
Activity of moxifloxacin against pathogens with decreased susceptibility to ciprofloxacinA Pong, K S Thomson, E S Moland, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1997
Beta-lactamases and detection of beta-lactam resistance in Enterobacter sppJ D Pitout, E S Moland, C C Sanders, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1995
New variant of TEM-10 beta-lactamase gene produced by a clinical isolate of proteus mirabilisT Palzkill, K S Thomson, C C Sanders, et al.
The Journal of Antimicrobial Chemotherapy|October 8, 1999
Molecular characterization of a multiply resistant Klebsiella pneumoniae encoding ESBLs and a plasmid-mediated AmpCN D Hanson, K S Thomson, E S Moland, et al.
Journal of Clinical Microbiology|December 4, 2009
Positive extended-spectrum-beta-lactamase (ESBL) screening results may be due to AmpC beta-lactamases more often than to ESBLsG K Munier, C L Johnson, J W Snyder, et al.
Antimicrobial Agents and Chemotherapy|June 13, 1998
beta-Lactamases responsible for resistance to expanded-spectrum cephalosporins in Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis isolates recovered in South AfricaJ D Pitout, K S Thomson, N D Hanson, et al.
Pageof 3